Cases and deaths have already outpaced totals for 2024, and new outbreaks have emerged in Gambia, Cameroon, and Mozambique.
The test the US Centers for Disease Control and Prevention uses to identify clade I mpox cases is 'most likely not reliable' for detection of the substrain identified in the study, the authors say.
Another mpox study today showed that dose-sparing vaccine administration of the Jynneos vaccine appeared to have worked.
Receive the latest infectious disease information.
The initiative is designed to accelerate testing, sequencing, capacity building, and local manufacturing for mpox and other priority pathogens.
Health officials facing depleted vaccine supplies are also tracking upticks in Nigeria, Liberia, Kenya, and Ghana, as well as in Togo and Mozambique.
The cases were reported in northern Mozambique near the Tanzanian border.
Despite declines in 2 high-burden countries, cases are rising in Burundi, Uganda, Ghana, Kenya, Liberia, and Guinea.
Though the surge in Sierra Leone has received much of the attention, cases are also rising in two other countries in West Africa: Ghana and Liberia.
Scientists estimate a precurser to the 2022 strain first emerged in Nigeria in August 2014 and spread to 11 Nigerian states before human infections were detected in 2017.
Population density and tourism are among factors driving infections in Sierra Leone, which made up 53% of mpox illnesses in Africa last week.
HHS received a list of 100 ways it could better prepare for and respond to public health emergencies such as pandemics.
Amid an ongoing vaccine shortage, more doses are arriving this week from Japan and France.
Togo's outbreak brings Africa's number of affected countries to 25, amid exponential spread in Sierra Leone.
